Dr. Schmidt Interviewed by the Scientific American
Post

“Semaglutide’s story becomes even more complicated in drug addiction. Addictive drugs such as cocaine and opioids are generally thought to “hijack” the brain’s natural reward pathways, says Heath Schmidt, a neuropharmacologist at the University of Pennsylvania. Over time, the brain … Read More

Schmidt Lab Findings Cited by the Wall Street Journal
Post

“We’re talking about a class of medications that could have efficacy in treating a variety of addictions: cocaine, opioids, nicotine, alcohol, all different addictive drugs with very different pharmacology,” said Heath Schmidt, a neuroscientist studying addiction at the University of … Read More

Videos
Page
BBC Conference Talk 2023 by Riley Merkel Schmidt Lab Elevator Pitch by Vanessa Weir Can Anti-Diabetic Drugs be Used to Treat Cocaine Use Disorder? by Dr. H.D. Schmidt Ben Talks Senior Research Update by Jennifer Ben Nathan
Areas of Study
Page

“To see what is in front of one’s nose needs a constant struggle” – George Orwell Novel roles for peripheral metabolic factors in substance use disorders Given that the search for effective pharmacotherapies for cocaine use disorder has, thus far, been fruitless, … Read More

Schmidt Lab in The Atlantic
Post

Two Schmidt Lab papers were recently cited in The Atlantic article, Did Scientists Accidentally Invent an Addiction Drug? , by Sarah Zhang.

Our nicotine findings highlighted by the Insider
Post

Our recent publication, “Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats”, and nicotine work were highlighted in an article by Insider.

Videos
Page
Can Anti-Diabetic Drugs be Used to Treat Cocaine Use Disorder? by Dr. H.D. Schmidt BBC Conference Talk 2023 by Riley Merkel Ben Talks Senior Research Update by Jennifer Ben Nathan Schmidt Lab Elevator Pitch by Vanessa Weir